ANNA LIVINGSTON: Open Payments
NPI 1205496361 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,394 in 103 payments from 19 companies in 2025. Trend: 2023 $2,015 · 2024 $2,029 · 2025 $2,394
Food & beverage: $2,294Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $433 |
| Galderma Laboratories, L.P. | 11 | $273 |
| UCB, Inc. | 13 | $233 |
| Incyte Corporation | 11 | $162 |
| Lilly USA, LLC | 6 | $139 |
| PFIZER INC. | 7 | $138 |
| Kerecis Limited | 2 | $134 |
| Organon LLC | 7 | $118 |
| ABBVIE INC. | 6 | $117 |
| LEO Pharma Inc. | 5 | $98 |
Products named: TREMFYA, NEMLUVIO, Bimzelx, OPZELURA, CIBINQO, DUPIXENT, Kerecis SurgiClose, TALTZ.
Industry payments across LA — which companies pay providers there.
